Site-Specific In-111-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
| dc.contributor.author | Dave Lumen | |
| dc.contributor.author | Simo Näkki | |
| dc.contributor.author | Surachet Imlimthan | |
| dc.contributor.author | Elisavet Lambidis | |
| dc.contributor.author | Mirkka Sarparanta | |
| dc.contributor.author | Wujun Xu | |
| dc.contributor.author | Vesa-Pekka Lehto | |
| dc.contributor.author | Anu J. Airaksinen | |
| dc.contributor.organization | fi=PET-keskus|en=Turku PET Centre| | |
| dc.contributor.organization | fi=kemian laitos|en=Department of Chemistry| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.27622076134 | |
| dc.converis.publication-id | 45078187 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/45078187 | |
| dc.date.accessioned | 2022-10-28T13:45:09Z | |
| dc.date.available | 2022-10-28T13:45:09Z | |
| dc.description.abstract | Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [In-111]In-DOTA-PEG(4)-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [In-111]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 +/- 1.7% of the injected activity/g in blood at 15 min for [In-111]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors. | |
| dc.identifier.eissn | 1999-4923 | |
| dc.identifier.jour-issn | 1999-4923 | |
| dc.identifier.olddbid | 184076 | |
| dc.identifier.oldhandle | 10024/167170 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/41549 | |
| dc.identifier.urn | URN:NBN:fi-fe2021042823319 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Airaksinen, Anu | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.affiliatedauthor | Dataimport, 2609820 PET Tutkimus | |
| dc.okm.discipline | 317 Pharmacy | en_GB |
| dc.okm.discipline | 317 Farmasia | fi_FI |
| dc.okm.internationalcopublication | not an international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | MDPI | |
| dc.publisher.country | Switzerland | en_GB |
| dc.publisher.country | Sveitsi | fi_FI |
| dc.publisher.country-code | CH | |
| dc.relation.articlenumber | ARTN 686 | |
| dc.relation.doi | 10.3390/pharmaceutics11120686 | |
| dc.relation.ispartofjournal | Pharmaceutics | |
| dc.relation.issue | 12 | |
| dc.relation.volume | 11 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/167170 | |
| dc.title | Site-Specific In-111-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model | |
| dc.year.issued | 2019 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- pharmaceutics-11-00686.pdf
- Size:
- 3.12 MB
- Format:
- Adobe Portable Document Format
- Description:
- Publisher's version